Coverage of Conditions and Treatments (Coverage Decisions)
Acupuncture* is a covered benefit with conditions for chronic migraine when that is an accepted condition on their workers’ compensation claim.
Conditions of coverage
This decision applies to adults (age 18 and older) for chronic migraine (as defined by the International Headache Society**). Acupuncture is a covered benefit with the following conditions:
- Must be diagnosed with chronic migraine by a qualified provider (per Washington State Department of Health),
- With a referral by the attending provider,
- Up to 24 sessions over the course of one year, and
- One additional treatment cycle may be considered at agency discretion; the agency may authorize up to 24 additional sessions that may occur any time after the completion of the initial, effective cycle, when the following criteria are met:
- Referred by the attending provider, and
- Individual has shown a significant improvement in symptoms on a validated scale for chronic migraine with the initial treatment cycle (e.g., a change of ≥ 4.5 points in the Migraine Disability Assessment Score [MIDAS] or a decrease of ≥6 points in the Headache Impact Test [HIT-6] Total Scores).
- Out of scope /data not reviewed for this decision:
- Other headache and migraine types not specified
Other Acupuncture Coverage Decisions:
Background Information
Treatment of chronic migraine and chronic tension-type headache was originally reviewed by the State Health Technology Clinical Committee (HTCC) in May 2017 and a determination was finalized on July 14, 2017. The Department adopted the coverage determination accordingly (Selected Treatments for Chronic Migraine or Tension-type Headache and Botulinum Toxins). Complete information on the HTCC determination is available at:
- Acupuncture policy as previously determined in Treatment of Chronic Migraine and Chronic Tension-Type Headache (20170519B)
In adopting this HTCC coverage determination, the Department has concluded that the determination does not conflict with any state statute. Any coverage for investigational treatment would be considered per